This is why, despite the exciting research, I do not currently offer BPC-157 injections or oral peptide supplements in my clinical practice
Y agrega que en pacientes con reganancia de peso despus de ciruga baritrica, estos frmacos para la obesidad podran ser una opcin para prdida de peso "con escaso riesgo y beneficio significativo"
10.1186/s12958-018-0343-0 68 XuJ.LeiY.ZhangX.LiJ.LinQ.WuX.et al (2025)
Patients who see the best results are already putting in the work and use the Build & Define protocol to optimize what their body does with that effort
Key players in this phase include major pharma sponsors, Contract Research Organizations (CROs), clinical trial networks, and regulatory consultants
While the science remains early, clinicians are increasingly paying attention to how these agents could potentially affect Parkinsons disease progression and symptoms